OPL Complete Profile

Otsuka Pakistan Limited was incorporated in February 1988 and commenced the commercial production of Intravenous Solutions in September 1989 at its factory located at Hub, Baluchistan.

Otsuka Pakistan is an indirect subsidiary of Otsuka Pharmaceutical company Japan, a multinational pharmaceutical company, that completed 100 years of dedication towards improving healthcare around the world in the year 2021. Otsuka Pakistan has been supplying world-class quality products to the Pakistani population which are the number one choice of clinicians in Pakistan. Otsuka Pakistan Limited is dealing mainly in IV solutions and has a wide range of Electrolytes Solutions, Carbohydrates Solutions, and Clinical Nutrition products.

Therapeutic Drugs are Otsuka Pakistan’s second line of business, currently consisting of Pletaal and Mucosta which are for diabetic and ulcer patients respectively. These are being imported from Otsuka Korea who has manufacturing license from Otsuka Japan.

Otsuka Pakistan’s third line of business is the medical devices segment which comprises of Made in Germany CE-marked Drug-eluting Coronary Stents, PTCA Balloon Catheters, and other Coronary Angioplasty Accessories and Electrophysiology products.

Otsuka Pakistan entered into Diagnostics Segment as well and launched the Urea Breath Test System (UBiT) i.e. a Point of Care Testing for Accurate Diagnosis and Confirmation of Helicobacter Pylori in the year 2019.

Otsuka Pakistan is committed to improving patient’s lives as we truly believe in our Vision of “Otsuka People Creating New Products for Better Health Worldwide”

Otsuka Pakistan Limited is an ISO 9001:2015, ISO 14001:2015 and OHSAS 18001:2007 Certified Company